治療用核医薬品の世界市場2019

QYResearchが発行した調査報告書(QYR9058236)
◆英語タイトル:Global Therapeutic Nuclear Medicines Sales Market Report 2019
◆商品コード:QYR9058236
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月15日(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、治療用核医薬品の世界市場について調査・分析し、治療用核医薬品のメーカー別販売量、市場シェア分析、種類別販売分析(ベータエミッタ、アルファエミッタ、近接照射療法製品)、用途別販売分析(甲状腺、骨転移、リンパ腫、内分泌腫瘍、その他)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・治療用核医薬品市場概要
・治療用核医薬品のメーカー別販売量・メーカー別シェア
・治療用核医薬品の種類別販売量(ベータエミッタ、アルファエミッタ、近接照射療法製品)
・治療用核医薬品の用途別販売量(甲状腺、骨転移、リンパ腫、内分泌腫瘍、その他)
・治療用核医薬品の地域別販売量・市場シェア
・治療用核医薬品のアメリカ市場規模(2014年-2019年)
・治療用核医薬品のヨーロッパ市場規模(2014年-2019年)
・治療用核医薬品の中国市場規模(2014年-2019年)
・治療用核医薬品の日本市場規模(2014年-2019年)
・治療用核医薬品の東南アジア市場規模(2014年-2019年)
・治療用核医薬品のインド市場規模(2014年-2019年)
・治療用核医薬品メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・治療用核医薬品のコスト分析
・治療用核医薬品販売チャネル、流通業者、顧客
・治療用核医薬品の世界市場動向・機会・成長要因・課題
・治療用核医薬品の種類別世界市場予測(ベータエミッタ、アルファエミッタ、近接照射療法製品)
・治療用核医薬品の用途別世界市場予測(甲状腺、骨転移、リンパ腫、内分泌腫瘍、その他)
・治療用核医薬品のアメリカ市場予測(2019年-2025年)
・治療用核医薬品のヨーロッパ市場予測(2019年-2025年)
・治療用核医薬品の中国市場予測(2019年-2025年)
・治療用核医薬品の日本市場予測(2019年-2025年)
・治療用核医薬品の東南アジア市場予測(2019年-2025年)
・治療用核医薬品のインド市場予測(2019年-2025年)
...
【レポートの概要】

The global Therapeutic Nuclear Medicines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear Medicines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
IBA Molecular Imaging

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Beta Emitters
Alpha Emitters
Brachytherapy Products

Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Others

【レポートの目次】

Table of Contents

Global Therapeutic Nuclear Medicines Sales Market Report 2019
1 Therapeutic Nuclear Medicines Market Overview
1.1 Therapeutic Nuclear MedicinesProduct Overview
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales Comparison by Types (2014-2025)
1.2.2 Beta Emitters
1.2.3 Alpha Emitters
1.2.4 Brachytherapy Products
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Sales Comparison by Application (2014-2025)
1.3.1 Thyroid
1.3.2 Bone Metastasis
1.3.3 Lymphoma
1.3.4 Endocrine Tumors
1.3.5 Others
1.4 Therapeutic Nuclear Medicines Market by Region
1.4.1 Global Therapeutic Nuclear Medicines Revenue Comparison by Region (2014-2025)
1.4.2 United States Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.3 Europe Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.4 China Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.5 Japan Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.6 Southeast Asia Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.4.7 India Therapeutic Nuclear Medicines Status and Prospect (2014-2025)
1.5 Global Therapeutic Nuclear Medicines Sales and Revenue (2014-2025)
1.5.1 Global Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2025)
1.5.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2025)

2 Therapeutic Nuclear Medicines by Company, Region, Type and Application
2.1 Global Therapeutic Nuclear Medicines Market Competition by Companies
2.1.1 Global Therapeutic Nuclear Medicines Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2014-2019)
2.2 Global Therapeutic Nuclear Medicines Sales and Revenue by Region
2.2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2014-2019)
2.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2014-2019)
2.3 Global Therapeutic Nuclear Medicines Sales and Revenue by Type
2.3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2014-2019)
2.3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2014-2019)
2.4 Global Therapeutic Nuclear Medicines Sales by Application

3 United States Therapeutic Nuclear Medicines Sales, Revenue and Price
3.1 United States Therapeutic Nuclear Medicines Sales and Revenue (2014-2019)
3.1.1 United States Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
3.1.2 United States Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
3.1.3 United States Therapeutic Nuclear Medicines Price Trend (2014-2019)
3.2 United States Therapeutic Nuclear Medicines Sales Market Share by Company
3.3 United States Therapeutic Nuclear Medicines Sales Market Share by Type
3.4 United States Therapeutic Nuclear Medicines Sales Market Share by Application

4 Europe Therapeutic Nuclear Medicines Sales, Revenue and Price
4.1 Europe Therapeutic Nuclear Medicines Sales and Value (2014-2019)
4.1.1 Europe Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
4.1.2 Europe Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
4.1.3 Europe Therapeutic Nuclear Medicines Price Trend (2014-2019)
4.2 Europe Therapeutic Nuclear Medicines Sales Market Share by Company
4.3 Europe Therapeutic Nuclear Medicines Sales Market Share by Type
4.4 Europe Therapeutic Nuclear Medicines Sales Market Share by Application

5 China Therapeutic Nuclear Medicines Sales, Revenue and Price
5.1 China Therapeutic Nuclear Medicines Sales and Revenue (2014-2019)
5.1.1 China Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
5.1.2 China Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
5.1.3 China Therapeutic Nuclear Medicines Price Trend (2014-2019)
5.2 China Therapeutic Nuclear Medicines Sales Market Share by Company
5.3 China Therapeutic Nuclear Medicines Sales Market Share by Type
5.4 China Therapeutic Nuclear Medicines Sales Market Share by Application

6 Japan Therapeutic Nuclear Medicines Sales, Revenue and Price
6.1 Japan Therapeutic Nuclear Medicines Sales and Value (2014-2019)
6.1.1 Japan Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
6.1.2 Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
6.1.3 Japan Therapeutic Nuclear Medicines Price Trend (2014-2019)
6.2 Japan Therapeutic Nuclear Medicines Sales Market Share by Company
6.3 Japan Therapeutic Nuclear Medicines Sales Market Share by Type
6.4 Japan Therapeutic Nuclear Medicines Sales Market Share by Application

7 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue and Price
7.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2014-2019)
7.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Therapeutic Nuclear Medicines Price Trend (2014-2019)
7.2 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Company
7.3 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Type
7.4 Southeast Asia Therapeutic Nuclear Medicines Sales Market Share by Application

8 India Therapeutic Nuclear Medicines Sales, Revenue and Price
8.1 India Therapeutic Nuclear Medicines Sales and Value (2014-2019)
8.1.1 India Therapeutic Nuclear Medicines Sales Growth Rate (2014-2019)
8.1.2 India Therapeutic Nuclear Medicines Revenue Growth Rate (2014-2019)
8.1.3 India Therapeutic Nuclear Medicines Price Trend (2014-2019)
8.2 India Therapeutic Nuclear Medicines Sales Market Share by Company
8.3 India Therapeutic Nuclear Medicines Sales Market Share by Type
8.4 India Therapeutic Nuclear Medicines Sales Market Share by Application

9 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business
9.1 Cardinal Health
9.1.1 Cardinal Health Therapeutic Nuclear Medicines Production Sites and Area Served
9.1.2 Therapeutic Nuclear Medicines Specification and Application
9.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Mallinckrodt
9.2.1 Mallinckrodt Therapeutic Nuclear Medicines Production Sites and Area Served
9.2.2 Therapeutic Nuclear Medicines Specification and Application
9.2.3 Mallinckrodt Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 GE Healthcare
9.3.1 GE Healthcare Therapeutic Nuclear Medicines Production Sites and Area Served
9.3.2 Therapeutic Nuclear Medicines Specification and Application
9.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Lantheus Medical Imaging
9.4.1 Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Sites and Area Served
9.4.2 Therapeutic Nuclear Medicines Specification and Application
9.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Bayer
9.5.1 Bayer Therapeutic Nuclear Medicines Production Sites and Area Served
9.5.2 Therapeutic Nuclear Medicines Specification and Application
9.5.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Bracco Imaging
9.6.1 Bracco Imaging Therapeutic Nuclear Medicines Production Sites and Area Served
9.6.2 Therapeutic Nuclear Medicines Specification and Application
9.6.3 Bracco Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Eczacibasi-Monrol Nuclear Products
9.7.1 Eczacibasi-Monrol Nuclear Products Production Sites and Area Served
9.7.2 Therapeutic Nuclear Medicines Specification and Application
9.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Nordion
9.8.1 Nordion Therapeutic Nuclear Medicines Production Sites and Area Served
9.8.2 Therapeutic Nuclear Medicines Specification and Application
9.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Advanced Accelerator Applications
9.9.1 Advanced Accelerator Applications Therapeutic Nuclear Medicines Production Sites and Area Served
9.9.2 Therapeutic Nuclear Medicines Specification and Application
9.9.3 Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 IBA Molecular Imaging
9.10.1 IBA Molecular Imaging Therapeutic Nuclear Medicines Production Sites and Area Served
9.10.2 Therapeutic Nuclear Medicines Specification and Application
9.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served

10 Therapeutic Nuclear Medicines Maufacturing Cost Analysis
10.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
10.4 Therapeutic Nuclear Medicines Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Therapeutic Nuclear Medicines Distributors List
11.3 Therapeutic Nuclear Medicines Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Therapeutic Nuclear Medicines Market Forecast
13.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast
13.1.1 Global Therapeutic Nuclear Medicines Sales Growth Forecast (2019-2025)
13.1.2 Global Therapeutic Nuclear Medicines Revenue Growth Forecast (2019-2025)
13.1.3 Global Therapeutic Nuclear Medicines Price Trend Forecast (2019-2025)
13.2 Global Therapeutic Nuclear Medicines Forecast by Region
13.2.1 Global Therapeutic Nuclear Medicines Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Therapeutic Nuclear Medicines Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Therapeutic Nuclear Medicines Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Therapeutic Nuclear Medicines Forecast by Type
13.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2019-2025)
13.3.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2019-2025)
13.3.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2019-2025)
13.4 Global Therapeutic Nuclear Medicines Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 治療用核医薬品の世界市場2019(Global Therapeutic Nuclear Medicines Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。